{
    "nct_id": "NCT03226119",
    "official_title": "HTLV Blot 2.4 Post-Market Clinical Study of Neurological Disorders and HTLV Positive Specimens",
    "inclusion_criteria": "All Specimens:\n\n* Male or female\n* Biorepository specimen de-identified of PHI\n* Specimen meets HTLV Blot 2.4 labeling collection/handling criteria\n\nHTLV Positive Specimens:\n\nSpecimens with a known positive infection of HTLV I, HTLV II or HTLV I/II\n\nNeurological Disorders:\n\nSpecimens with a diagnosis or symptoms consistent with any of the following neurological disorders:\n\n* Acute Disseminated Encephalitis\n* Amyotrophic Lateral Sclerosis (ALS)\n* Autonomic Dysfunction\n* Conus Medularis Syndrome\n* Chronic Inflammatory Demyelinating Polyneuropathy\n* Dermatomyositis\n* HTLV associated myelopathy-tropical spastic paraparesis (HAM-TSP)\n* Meningitis\n* Mild Cognitive Impairment\n* Multiple Sclerosis (MS)\n* Polymyositis\n* Spastic Paraparesis\n* Sciatica\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "HTLV Infected:\n\n* specimens with a known infection or history of HIV, HCV or HBV\n* specimens not meeting specimen labeling collection / handling criteria\n\nNeurological Disorders\n\n* specimens not meeting specimen labeling collection / handling criteria",
    "miscellaneous_criteria": ""
}